“Retirement Secret” Showed 995% Gain Last Time We Shared It

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

David J. Schlanger net worth and biography

David Schlanger Biography and Net Worth

CEO of Progyny

David Schlanger serves as CEO of Progyny Inc.

Schlanger has been at the helm of Progyny since 2017, leading the fertility benefits management company in providing inclusive and comprehensive fertility care that benefits patients, employers and physicians.

Prior to Progyny, Schlanger spent 15 years with WebMD. His most recent role at the medical internet company was as CEO from 2013 to 2016, after serving as interim CEO from May to August 2013. During his tenure at WebMD, Schlanger led over 1,700 employees to grow revenue from $470 million to over $700 million.

Other roles he held at the company included senior vice president of strategic and corporate development and senior vice president of corporate development, the latter of which he held for 10 years.

Schlanger’s early career included a five-year stint as an associate with Latham & Watkins, where he was a senior transactions attorney. From 1990 to 1993, he worked as the vice president of acquisitions for Medco Containment Services before joining Merck as their executive director of business development from 1993 to 1994. Directly prior to his time at WebMD, Schlanger spent six years as the senior vice president for corporate development at Medical Manager Corp.

Schlanger holds a bachelor’s degree in economics from Georgetown University, and he earned his J.D. from the University of Michigan Law School.

What is David J. Schlanger's net worth?: The estimated net worth of David J. Schlanger is at least $2.72 million as of April 1st, 2024. Mr. Schlanger owns 83,631 shares of Progyny stock worth more than $2,718,008 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Schlanger may own. Additionally, Mr. Schlanger receives an annual salary of $510,410.00 as CEO at Progyny. Learn More about David J. Schlanger's net worth.
How old is David J. Schlanger?: Mr. Schlanger is currently 65 years old. There are 4 older executives and no younger executives at Progyny. Learn More on David J. Schlanger's age.
What is David J. Schlanger's salary?: As the CEO of Progyny, Inc., Mr. Schlanger earns $510,410.00 per year. There are 3 executives that earn more than Mr. Schlanger. The highest earning executive at Progyny is Mr. Peter Anevski, CEO & Director, who commands a salary of $1,010,000.00 per year. Learn More on David J. Schlanger's salary.
How do I contact David J. Schlanger?: The corporate mailing address for Mr. Schlanger and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on David J. Schlanger's contact information.
Has David J. Schlanger been buying or selling shares of Progyny?: Over the course of the past ninety days, David J. Schlanger has sold $37,520.00 in Progyny stock. Most recently, David J. Schlanger sold 1,000 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $37.52, for a transaction totalling $37,520.00. Following the completion of the sale, the chairman now directly owns 83,631 shares of the company's stock, valued at $3,137,835.12. Learn More on David J. Schlanger's trading history.
Who are Progyny's active insiders?: Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?: In the last twelve months, insiders at the sold shares 36 times. They sold a total of 3,771,931 shares worth more than $151,880,735.89. The most recent insider tranaction occured on April, 1st when Chairman David J Schlanger sold 1,000 shares worth more than $37,520.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.
Information on this page was last updated on 4/1/2024.

David J. Schlanger Insider Trading History at Progyny

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Sell	1,000	$37.52	$37,520.00	83,631
3/27/2024	Sell	71,272	$37.80	$2,694,081.60	86,312
3/25/2024	Sell	2,597	$37.65	$97,777.05	86,312
3/21/2024	Sell	5,826	$37.74	$219,873.24	86,312
2/5/2024	Sell	20,000	$38.50	$770,000.00	86,312
1/8/2024	Sell	66,002	$37.88	$2,500,155.76	86,312
1/2/2024	Sell	13,998	$37.58	$526,044.84	88,439
12/26/2023	Sell	80,000	$37.93	$3,034,400.00	88,439
12/21/2023	Sell	80,000	$37.65	$3,012,000.00	88,439
12/14/2023	Sell	1,063	$37.53	$39,894.39	88,439
7/12/2023	Sell	38,687	$38.64	$1,494,865.68	70,806
7/3/2023	Sell	18,856	$38.76	$730,858.56	73,487
6/5/2023	Sell	41,666	$40.00	$1,666,640.00	73,487
6/1/2023	Sell	41,667	$37.55	$1,564,595.85	73,487
5/10/2023	Sell	34,593	$37.72	$1,304,847.96	73,487
5/8/2023	Sell	67,887	$35.11	$2,383,512.57	73,487
4/24/2023	Sell	10,224	$35.00	$357,840.00	73,487
4/21/2023	Sell	37,296	$35.01	$1,305,732.96	73,487
3/2/2023	Sell	41,667	$36.11	$1,504,595.37	76,168
2/6/2023	Sell	5,824	$35.26	$205,354.24	76,168
2/3/2023	Sell	100,000	$35.54	$3,554,000.00	76,168
1/31/2023	Sell	1,285	$35.00	$44,975.00	74,716
11/4/2022	Sell	25,020	$39.30	$983,286.00	82,548
10/25/2022	Sell	25,989	$39.62	$1,029,684.18	82,548
10/20/2022	Sell	2,200	$39.37	$86,614.00	82,548
10/17/2022	Sell	1,300	$39.34	$51,142.00	82,548
10/14/2022	Sell	1,850	$39.41	$72,908.50	82,548
10/6/2022	Sell	56,852	$40.26	$2,288,861.52	82,548
9/7/2022	Sell	67,779	$39.46	$2,674,559.34	82,548
8/9/2022	Sell	41,667	$41.65	$1,735,430.55	82,548
6/27/2022	Sell	1,452	$31.21	$45,316.92	82,548
4/4/2022	Sell	50,000	$49.80	$2,490,000.00	84,000
4/1/2022	Sell	50,000	$51.82	$2,591,000.00	84,000
3/2/2022	Sell	50,000	$44.01	$2,200,500.00
2/28/2022	Sell	139,776	$39.13	$5,469,434.88
2/11/2022	Sell	1,000	$42.00	$42,000.00
1/3/2022	Sell	50,000	$51.17	$2,558,500.00
12/27/2021	Sell	10,900	$52.80	$575,520.00
11/3/2021	Sell	50,000	$61.34	$3,067,000.00
11/1/2021	Sell	50,000	$62.24	$3,112,000.00
10/4/2021	Sell	50,000	$57.34	$2,867,000.00
10/1/2021	Sell	50,000	$57.26	$2,863,000.00
9/3/2021	Sell	50,000	$57.17	$2,858,500.00	50,000
8/26/2021	Sell	34,691	$51.61	$1,790,402.51	115,309
6/24/2021	Sell	105,987	$59.46	$6,301,987.02
6/2/2021	Sell	50,000	$63.70	$3,185,000.00	50,000
5/5/2021	Sell	50,000	$53.21	$2,660,500.00	50,000
5/3/2021	Sell	50,000	$55.79	$2,789,500.00	50,000
4/8/2021	Sell	36,676	$45.58	$1,671,692.08	300
4/6/2021	Sell	112,020	$46.10	$5,164,122.00	300
4/1/2021	Sell	1,004	$46.19	$46,374.76	1,004
3/12/2021	Sell	55,430	$47.57	$2,636,805.10	13,003
3/10/2021	Sell	13,003	$47.50	$617,642.50	13,003
2/3/2021	Sell	50,000	$47.84	$2,392,000.00	50,000
2/1/2021	Sell	50,000	$47.92	$2,396,000.00	50,000
1/6/2021	Sell	20,010	$43.29	$866,232.90
1/4/2021	Sell	40,000	$42.47	$1,698,800.00
12/3/2020	Sell	40,000	$37.12	$1,484,800.00
12/1/2020	Sell	40,000	$35.50	$1,420,000.00
11/11/2020	Sell	36,940	$29.38	$1,085,297.20
11/9/2020	Sell	40,000	$29.30	$1,172,000.00
11/5/2020	Sell	500	$27.65	$13,825.00
10/5/2020	Sell	40,000	$29.43	$1,177,200.00
10/1/2020	Sell	40,000	$28.73	$1,149,200.00
9/28/2020	Sell	26,331	$28.54	$751,486.74
9/25/2020	Sell	40,000	$28.40	$1,136,000.00
9/15/2020	Sell	2,214	$28.58	$63,276.12
8/10/2020	Sell	46,521	$27.72	$1,289,562.12	592,489
8/7/2020	Sell	1,000	$27.49	$27,490.00	592,489
8/4/2020	Sell	104	$27.24	$2,832.96	600,010
7/9/2020	Sell	20,000	$25.94	$518,800.00	600,010
7/7/2020	Sell	20,000	$25.85	$517,000.00	600,010
7/2/2020	Sell	40,000	$25.99	$1,039,600.00	600,010
6/8/2020	Sell	20,000	$25.07	$501,400.00	591,794
6/5/2020	Sell	58,075	$24.93	$1,447,809.75	591,794
6/3/2020	Sell	6,741	$24.74	$166,772.34	600,010
6/1/2020	Sell	20,000	$24.82	$496,400.00	600,010
5/15/2020	Sell	20,000	$24.81	$496,200.00	631,498
5/13/2020	Sell	51,488	$25.14	$1,294,408.32	631,498
5/11/2020	Sell	8,512	$22.17	$188,711.04	600,010
5/8/2020	Sell	20,000	$22.73	$454,600.00	600,010
10/29/2019	Sell	960,007	$16.39	$15,734,514.73

David J. Schlanger Buying and Selling Activity at Progyny

Progyny Company Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Today's Range

Now: $32.50

$32.08

$32.65

50 Day Range

MA: $36.02

$31.88

$40.79

2 Week Range

Now: $32.50

$29.44

$44.95

Volume

588,643 shs

Average Volume

659,017 shs

Market Capitalization

$3.12 billion

P/E Ratio

52.42

Dividend Yield

N/A

Beta

1.48

“Retirement Secret” Showed 995% Gain Last Time We Shared It

From Stansberry Research | Ad

Find out why right here (and see what you can do to get in too with just a few dollars).

David Schlanger Biography and Net Worth

What is David J. Schlanger's net worth?

How old is David J. Schlanger?

What is David J. Schlanger's salary?

How do I contact David J. Schlanger?

Has David J. Schlanger been buying or selling shares of Progyny?

Who are Progyny's active insiders?

Are insiders buying or selling shares of Progyny?